Why I like Warfarin and Why You Should too

I am aware the love for Novel Oral Anticoagulants (NOACs) is growing and that warfarin is falling out of favour, especially in the setting of stroke prevention in atrial fibrillation or in the management of venous thromboembolism.  But hear me out on this one. Warfarin should stay and here’s why.

Continue reading Why I like Warfarin and Why You Should too


Single Pill Combination for Hypertension

This year for Hypertension Awareness Month and World Hypertension Day (May 17), I want to discuss about the role of single pill combination in the management of hypertension.  Single Pill Combination has been consistently recommended in various Hypertension Guidelines to assist with blood pressure control.  However, there is no great resource to guide available options of single pill combination in Ontario.

Continue reading Single Pill Combination for Hypertension

Talk Diabetes 2018 – Part I

Talk Diabetes 2018 was an education event presented by The Diabetes Education and Management Centre of Kingston Health Sciences Centre – Hotel Dieu Site on May 11, 2018. It was a day packed with many valuable contents to be shared among health care professionals looking for an updates in diabetes, especially with the recent release of the 2018 Diabetes Canada Clinical Practice Guidelines.  Here are some notes I took:

Continue reading Talk Diabetes 2018 – Part I

Mental Health Resources for Pharmacists

As we begin the dialogue this week on mental health awareness week, I also want to highlight some useful resources for pharmacists. Here are few of my favourites:

Continue reading Mental Health Resources for Pharmacists

Immunization Record – Room for Improvement?

From Apr 21 to 28, it’s National Immunization Awareness Week in Canada. So I think it is timely to share this story on immunization record. I have received few “threatening” letters from Public Health that my daughter would soon be expelled from school because her immunization records were incomplete.

Continue reading Immunization Record – Room for Improvement?

SUSTAIN-6: Another Medication for Diabetes with Cardiovascular Benefits?

Semaglutide (Ozempic) recently received its Notice of Compliance from Health Canada and is therefore now available for Canadians with Type 2 diabetes. So it only makes sense to take a closer look at its evidence, particularly the evidence for its cardiovascular benefits which was studied in SUSTAIN-6 and published in New England Journal of Medicine in 2016..

Continue reading SUSTAIN-6: Another Medication for Diabetes with Cardiovascular Benefits?